Search Result
List
2017-02-24 - 2018-12-31
Others
-
Condition/Disease
-
Test Drug
Participate Sites
4Sites
Terminated3Sites
2018-12-06 - 2025-12-31
Phase II
-
Condition/Disease
-
Test Drug
Participate Sites
8Sites
Recruiting3Sites
Terminated4Sites
Division of Hematology & Oncology
2016-12-29 - 2023-09-28
Phase III
-
Condition/Disease
-
Test Drug
Participate Sites
9Sites
Recruiting6Sites
Terminated2Sites
2015-08-14 - 2024-05-01
Phase III
-
Condition/Disease
-
Test Drug
Participate Sites
9Sites
Recruiting4Sites
Terminated4Sites
Division of Hematology & Oncology
2017-04-27 - 2018-12-31
Phase I
-
Condition/Disease
Gastric Cancer/Esophageal Cancer/Gastro-esophageal Cancer
-
Test Drug
Oraxol + Ramucirumab
Participate Sites
7Sites
Terminated6Sites
Division of Radiation Therapy
2017-08-24 - 2019-09-30
Phase III
-
Condition/Disease
Small-Cell Lung Cancer (SCLC)
-
Test Drug
Durvalumab; Tremelimumab
Participate Sites
11Sites
Terminated10Sites
Division of Hematology & Oncology
2015-09-16 - 2017-06-30
Phase III
-
Condition/Disease
Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Compensated Cirrhosis
-
Test Drug
ABT-450/Ritonavir/ABT-267, ABT-333, Ribavirin
Participate Sites
6Sites
Terminated5Sites
Digestive System Department
2015-10-20 - 2017-05-30
Phase III
-
Condition/Disease
Chronic Hepatitis C Virus Genotype 2 Infection
-
Test Drug
ABT-493/ABT-530
Participate Sites
7Sites
Terminated4Sites
Study ended1Sites
Digestive System Department
2014-07-01 - 2020-12-31
Phase III
-
Condition/Disease
Advanced Nasopharyngeal Carcinoma
-
Test Drug
Epstein-Barr virus-specific autologous cytotoxic T lymphocytes
Participate Sites
8Sites
Terminated7Sites
Division of Hematology & Oncology
2017-03-01 - 2019-12-31
Phase III
-
Condition/Disease
Advanced or Metastatic Gastric Cancer
-
Test Drug
Apatinib
Participate Sites
10Sites
Terminated8Sites
Division of Hematology & Oncology
